Accenture (ACN)
(Delayed Data from NYSE)
$360.71 USD
+4.58 (1.29%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $360.72 +0.01 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$360.71 USD
+4.58 (1.29%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $360.72 +0.01 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth F Momentum C VGM
Zacks News
The Zacks Analyst Blog Highlights Honeywell International, Accenture, City Holding and First United
by Zacks Equity Research
Honeywell International, Accenture, City Holding and First United are included in this Analyst Blog.
Should You Invest in the iShares U.S. Industrials ETF (IYJ)?
by Zacks Equity Research
Sector ETF report for IYJ
Time to Buy These 4 Stocks With Risking Dividend Yields?
by Ritujay Ghosh
Honeywell International (HON), Accenture (ACN), City Holding Company (CHCO) and First United (FUNC) recently announced dividend hikes.
Accenture, Publicis Partner With Mondelez to Boost AI Marketing
by Zacks Equity Research
The partnership is set to enable ACN to solidify its position as a frontrunner in AI-driven solutions while expanding its influence in the CPG industry.
Why Accenture (ACN) International Revenue Trends Deserve Your Attention
by Zacks Equity Research
Review Accenture's (ACN) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Unisys Rises 38% in 3 Months: Should Investors Buy UIS Stock?
by Aniruddha Ganguly
UIS is an attractive stock for growth-oriented investors, given its portfolio strength, and strong partner base.
Company News for Sep 27, 2024
by Zacks Equity Research
Companies in The News Are: JBL, ACN, WFC, XOM
Accenture's Q4 Earnings & Revenues Beat Estimates, Increase Y/Y
by Zacks Equity Research
ACN's fourth-quarter fiscal 2024 earnings and revenues increase year over year.
Accenture (ACN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Accenture (ACN) give a sense of how the business performed in the quarter ended August 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Accenture (ACN) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Accenture (ACN) delivered earnings and revenue surprises of 0.72% and 0.40%, respectively, for the quarter ended August 2024. Do the numbers hold clues to what lies ahead for the stock?
Check Point Shares Rise 28% YTD: How Should You Play the Stock?
by Zacks Equity Research
CHKP shares benefit from acquisitions and expanding public sector clientele. However, stretched valuation is a concern.
Why Accenture (ACN) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
TD SYNNEX Gears Up to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
SNX's fiscal Q3 performance is expected to have been affected by a soft IT spending environment amid global recessionary concerns.
Accenture (ACN) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Accenture (ACN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended August 2024.
Is Accenture Stock a Smart Buy Before Q4 Earnings Results?
by Arghyadeep Bose
ACN is likely to have benefited from an increase in bookings and the use of GenAI to conduct large-scale transformation during the fiscal fourth quarter.
Factors to Note Ahead of BlackBerry's Q2 Earnings Release
by Zacks Equity Research
BB's second-quarter performance is likely to have gained from strengthening SecuSmart business and higher revenues from royalties and professional services.
Will Revenue Contraction Affect Jabil's Q4 Earnings Results?
by Zacks Equity Research
JBL is expected to report a revenue decline year over year in the fourth quarter of fiscal 2024, owing to weakness in multiple verticals.
Accenture (ACN) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Accenture (ACN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Endava PLC Sponsored ADR (DAVA) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Endava (DAVA) delivered earnings and revenue surprises of -3.45% and 1.35%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Accenture (ACN) Ahead of Earnings?
by Zacks Equity Research
Accenture (ACN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Accenture PLC (ACN) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Accenture (ACN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Company News for Sep 18, 2024
by Zacks Equity Research
Companies In The News Are: FERG, MSFT, INTC, ACN.
Accenture (ACN) Rises Higher Than Market: Key Facts
by Zacks Equity Research
Accenture (ACN) closed the most recent trading day at $354.12, moving +1.3% from the previous trading session.
Here's Why You Should Add Accenture Stock to Your Portfolio
by Zacks Equity Research
ACN's broader growth strategy focuses on delivering comprehensive value to its stakeholders through technology.
Wall Street Analysts Think Accenture (ACN) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Accenture (ACN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?